Has COVID-19 changed the future of pharmaceutical regulation?

FHS
June 30, 2023
7:49 am

Has COVID-19 revolutionized the future of regulation of medicine development and authorization or are we simply responding to an unprecedented global pandemic? Our Head of Regulatory Affairs and Enhanced Services,

Opinion | Xylazine: New Drug, Same Old Mistakes

Marino is a medical toxicologist, addiction medicine specialist, and emergency physician. Reports of the drug xylazine being detected in overdoses across the U.S. have been

July 11, 2023

The Supreme Court could overturn the Chevron doctrine. Here’s how that could hurt the FDA

The Supreme Court on Wednesday heard oral arguments in two cases having to do with federal oversight of herring fishing — but the court’s decisions

January 19, 2024

Study shows link between personal wealth and health care costs in people with Alzheimer’s disease

Finland has a strong public health care system; nevertheless, personal wealth is associated with the costs of hospital care and medication in people with Alzheimer’s

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.